Praxis Precision stockholders elect directors, ratify EY, approve say-on-pay at 2025 annual meeting

Praxis Precision Medicines, Inc.

Elected Jeffrey Chodakewitz and Merit Cudkowicz as Class II directors with 14.6M and 17.5M votes for, respectively.
Ratified Ernst & Young as independent auditor for FY2025: 18.36M for, 7,630 against.
Advisory 'say-on-pay' approved: 10.67M for (60.7%) vs 6.92M against (39.3%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.